Article Figures & Data
Figures
- Figure 1.
Effect of Alirocumab and Ezetimibe on Low-Density Lipoprotein Cholesterol Over 24 Weeks
LDL-C, low-density lipoprotein cholesterol; Q2W, every other week.
Reproduced with permission from PM Moriarty, MD.
Tools
Alirocumab Has Greater Reduction of LDL-C Than Ezetimibe in Patients with Statin Intolerance
Permalink:
